Cepheid Collaborates with CDC to Enhance National Pandemic Response Through Rapid Diagnostics Cepheid joins forces with the CDC to advance rapid diagnostic technologies, aimed at enhancing the U.S.'s preparedness for future pandemics and public health crises.

Cepheid Collaborates with CDC to Enhance National Pandemic Response Through Rapid Diagnostics #United_States #Sunnyvale #CDC #Rapid_Diagnostics #Cepheid

Global Lateral Flow Assays Market Expected to Hit $17.44 Billion by 2033 Amid Accelerated Growth The lateral flow assays market is poised for significant growth, expected to reach $17.44 billion by 2033, driven by technological advancements and rising health demands.

Global Lateral Flow Assays Market Expected to Hit $17.44 Billion by 2033 Amid Accelerated Growth #USA #San_Francisco #Infectious_Diseases #Rapid_Diagnostics #Lateral_Flow_Assays

Rapid Diagnostics Market Value to Surge to $24.28 Billion by 2032 Fueled by Expanding Healthcare Needs The rapid diagnostics market is set to grow dramatically, reaching $24.28 billion by 2032, driven by technological innovations and increased disease prevalence.

Rapid Diagnostics Market Value to Surge to $24.28 Billion by 2032 Fueled by Expanding Healthcare Needs #United_States #healthcare_technology #Redding #Rapid_Diagnostics #Point-of-Care

Early Bird Registration Now Open for 2025 Advanced Lateral Flow Conference in California Secure discounted early bird registration for the 2025 Advanced Lateral Flow Conference, offering insightful sessions and networking opportunities.

Early Bird Registration Now Open for 2025 Advanced Lateral Flow Conference in California #United_States #La_Jolla #DCN_Dx #Advanced_Lateral_Flow #Rapid_Diagnostics